Clinical Trials Directory

Trials / Completed

CompletedNCT04951869

: Protescal: Prevention of Hypertrophic Scar and Keloid Formation Post Caesarean Section

Assessing the Effectiveness of Protescal In Preventing Post Caesarean Section Hypertrophic Scar and Keloid

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Universiti Kebangsaan Malaysia Medical Centre · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

This study aimed to evaluate the effectiveness of Protescal in preventing post caesarean section hypertrophic scar and keloid formation.

Detailed description

A randomized controlled trial was conducted for six months involving 90 women who underwent caesarean section without any history of previous abdominal surgery and who were planning for further pregnancy. They were randomized into two groups. The Protescal group was given Protescal gel which was applied over the uterine incision site and subcutaneous tissue layer prior to skin closure (n = 45), whereas in the control group, no Protescal gel was applied (n = 45). The primary outcome was to assess the healing of the external scar.

Conditions

Interventions

TypeNameDescription
DRUGProtescal gelProtescal gel (0.5 mL) was again applied over the subcutaneous tissue prior to skin closure in Protescal group

Timeline

Start date
2017-04-26
Primary completion
2017-10-31
Completion
2017-11-16
First posted
2021-07-07
Last updated
2021-07-07

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT04951869. Inclusion in this directory is not an endorsement.